Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03873545 · ClinicalTrials.gov registry record
Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
A clinical trial of Cartilage Injury and Cartilage Damage, sponsored by AlloSource.
- Active
- Registry status
- 34
- Enrollment target
- 3
- Study locations
NCT03873545: Active study of Cartilage Injury and Cartilage Damage, sponsored by AlloSource.
NCT03873545 is a study of Cartilage Injury and Cartilage Damage that is active but no longer recruiting, run by AlloSource. The registered enrollment target is 34 participants, below the 429-participant average among 4 other Cartilage Injury trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03873545, a study of Cartilage Injury and Cartilage Damage, is active but no longer recruiting, sponsored by AlloSource.
- ACTIVE NOT RECRUITING
- Registry status
- 34 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this clinical study is to evaluate the use of ProChondrix Cryopreserved Osteochondral Allograft to obtain evidence of effectiveness, defined as an improvement in physical function and pain, when used on a symptomatic cartilage defect on the femoral condyle or patella in a mechanically stable knee.
Primary Outcome
Change in physical pain and function as assessed by IKDC score from baseline to 60 months post-surgery
Conditions Studied
Interventions
- PROCEDURE Cryopreserved Osteochondral Allograft
Study Locations (3)
Illinois
- Midwest Orthopaedics at Rush - Chicago
Kentucky
- University of Kentucky Research Foundation - Lexington
Ohio
- Beacon Orthopaedics & Sports Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-03-18 |
| Est. Completion | 2028-12-30 |
What the registry record for NCT03873545 still lists
NCT03873545 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 429-participant average among 4 other Cartilage Injury trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Cartilage Injury appearing as the primary indexed condition, and to 1 intervention - of which Cryopreserved Osteochondral Allograft is the first listed.
NCT03873545 reports a single indexed study location in Illinois, Kentucky, Ohio.
Frequently Asked Questions
What is clinical trial NCT03873545 about?
NCT03873545 is a clinical study titled "Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella". The purpose of this clinical study is to evaluate the use of ProChondrix Cryopreserved Osteochondral Allograft to obtain evidence of effectiveness, defined as an improvement in physical function and pain, when used on a symptomatic cartilage defect on the femoral condyle or patella in a mechanically...
What is the current status of trial NCT03873545?
This trial is currently active not recruiting. The enrollment target is 34 participants. The study started on 2019-03-18. Estimated completion is 2028-12-30.
What conditions does trial NCT03873545 study?
This clinical trial studies the following conditions: Cartilage Injury, Cartilage Damage.
What interventions are being tested in trial NCT03873545?
The interventions under investigation include: Cryopreserved Osteochondral Allograft (PROCEDURE).
Who is sponsoring clinical trial NCT03873545?
This trial is sponsored by AlloSource, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03873545 being conducted?
This trial has 3 study locations across Illinois, Kentucky, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cartilage Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Hyalex Early Feasibility Study (EFS)
RECRUITING · NA
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation
COMPLETED · NA
-
Prospective Registry of Anterior Cruciate Ligament Reconstructions
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI